Nifty
Sensex
:
:
10829.35
36701.16
88.00 (0.82%)
228.23 (0.63%)

Pharmaceuticals & Drugs

Rating :
51/99  (View)

BSE: 506690 | NSE: UNICHEMLAB

173.00
-1.05 (-0.60%)
23-Aug-2019 | 3:44PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  173.60
  •  173.95
  •  170.50
  •  174.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  27660
  •  47.85
  •  239.40
  •  160.15

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,221.54
  • 43.38
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,220.22
  • 4.61%
  • 0.45

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.62%
  • 4.51%
  • 31.22%
  • FII
  • DII
  • Others
  • 0.14%
  • 6.18%
  • 7.33%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.52
  • -2.21
  • -11.72

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -23.82
  • -32.84
  • -56.08

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.31
  • 25.16
  • 25.30

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.77
  • 1.72
  • 1.39

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.23
  • 12.84
  • 11.58

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Net Sales
297.74
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
317.95
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
-20.22
0.00
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
-6.79%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
26.26
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
1.28
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
18.25
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
-13.49
0.00
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
-7.53
0.00
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
-5.96
0.00
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
-2.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
-0.88
0.00
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
-
1,188.19
1,383.31
1,540.06
1,332.65
1,201.79
1,133.45
1,080.80
875.46
824.04
747.39
Net Sales Growth
-
-14.11%
-10.18%
15.56%
10.89%
6.03%
4.87%
23.46%
6.24%
10.26%
 
Cost Of Goods Sold
-
364.19
274.97
188.77
386.97
378.57
332.84
343.06
278.55
237.98
225.17
Gross Profit
-
823.99
1,108.34
1,351.28
945.67
823.23
800.61
737.75
596.91
586.07
522.22
GP Margin
-
69.35%
80.12%
87.74%
70.96%
68.50%
70.63%
68.26%
68.18%
71.12%
69.87%
Total Expenditure
-
1,269.21
1,361.75
1,357.62
1,168.77
1,100.79
955.75
910.06
759.42
674.08
576.53
Power & Fuel Cost
-
76.39
49.23
41.62
38.25
39.39
35.97
31.36
26.22
22.50
16.23
% Of Sales
-
6.43%
3.56%
2.70%
2.87%
3.28%
3.17%
2.90%
2.99%
2.73%
2.17%
Employee Cost
-
239.32
200.64
169.04
255.92
223.20
187.37
164.88
140.06
123.99
99.31
% Of Sales
-
20.14%
14.50%
10.98%
19.20%
18.57%
16.53%
15.26%
16.00%
15.05%
13.29%
Manufacturing Exp.
-
136.15
125.30
103.70
150.54
145.03
137.05
119.15
101.54
102.67
77.15
% Of Sales
-
11.46%
9.06%
6.73%
11.30%
12.07%
12.09%
11.02%
11.60%
12.46%
10.32%
General & Admin Exp.
-
239.66
598.79
744.66
167.66
153.29
127.77
104.73
88.54
79.74
71.83
% Of Sales
-
20.17%
43.29%
48.35%
12.58%
12.76%
11.27%
9.69%
10.11%
9.68%
9.61%
Selling & Distn. Exp.
-
197.24
111.64
107.77
166.84
157.12
134.03
135.93
116.00
106.52
80.88
% Of Sales
-
16.60%
8.07%
7.00%
12.52%
13.07%
11.82%
12.58%
13.25%
12.93%
10.82%
Miscellaneous Exp.
-
16.26
1.18
2.06
2.58
4.19
0.73
10.97
8.50
0.70
80.88
% Of Sales
-
1.37%
0.09%
0.13%
0.19%
0.35%
0.06%
1.01%
0.97%
0.08%
0.80%
EBITDA
-
-81.02
21.56
182.44
163.88
101.00
177.70
170.74
116.04
149.96
170.86
EBITDA Margin
-
-6.82%
1.56%
11.85%
12.30%
8.40%
15.68%
15.80%
13.25%
18.20%
22.86%
Other Income
-
98.41
3,278.32
5.50
19.11
20.72
42.38
16.96
12.50
8.32
7.98
Interest
-
7.52
8.01
3.36
2.90
3.04
3.19
3.29
4.08
2.39
2.38
Depreciation
-
67.37
50.51
43.52
38.79
41.27
45.72
38.34
30.43
29.22
23.21
PBT
-
-57.50
3,241.36
141.07
141.31
77.41
171.17
146.07
94.03
126.66
153.24
Tax
-
-33.64
696.23
32.58
29.30
2.13
43.00
32.85
22.77
31.68
30.43
Tax Rate
-
58.50%
21.48%
23.09%
21.27%
2.75%
25.12%
22.49%
24.22%
25.01%
19.86%
PAT
-
-23.87
2,545.13
108.49
108.48
75.28
128.16
113.23
71.26
94.98
122.81
PAT before Minority Interest
-
-23.87
2,545.13
108.49
108.48
75.28
128.16
113.23
71.26
94.98
122.81
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
-2.01%
183.99%
7.04%
8.14%
6.26%
11.31%
10.48%
8.14%
11.53%
16.43%
PAT Growth
-
-100.94%
2245.96%
0.01%
44.10%
-41.26%
13.19%
58.90%
-24.97%
-22.66%
 
Unadjusted EPS
-
-3.38
280.60
11.96
11.86
8.31
18.69
12.52
7.89
10.53
34.14

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
2,619.91
2,680.08
1,063.62
954.33
867.52
816.61
727.07
660.58
617.70
562.92
Share Capital
14.08
14.07
18.18
18.17
18.15
18.13
18.09
18.06
18.05
18.03
Total Reserves
2,601.99
2,665.42
1,044.00
935.01
848.52
797.74
707.98
641.80
598.85
544.19
Non-Current Liabilities
10.10
41.77
64.49
76.02
74.21
97.72
94.31
92.67
87.44
70.46
Secured Loans
0.00
0.33
0.44
22.98
20.35
24.65
20.89
20.47
19.01
15.29
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
23.49
22.72
20.48
Long Term Provisions
14.60
10.76
25.33
12.58
8.88
7.64
9.19
10.24
7.90
0.00
Current Liabilities
502.92
463.51
392.62
275.09
211.76
230.32
251.12
233.30
176.15
165.34
Trade Payables
221.41
226.23
210.73
163.95
138.23
150.52
156.63
140.30
109.99
115.14
Other Current Liabilities
68.45
63.03
68.01
60.56
45.86
32.99
36.65
34.28
26.00
14.56
Short Term Borrowings
199.67
150.29
97.62
12.93
1.63
1.04
6.17
25.42
9.04
0.00
Short Term Provisions
13.39
23.97
16.25
37.65
26.05
45.78
51.67
33.30
31.13
35.64
Total Liabilities
3,132.93
3,185.36
1,520.73
1,305.44
1,153.49
1,144.65
1,072.50
986.55
881.29
798.72
Net Block
806.29
574.45
487.22
402.60
415.99
419.29
447.76
408.39
377.31
333.35
Gross Block
975.96
689.74
561.37
439.53
724.65
688.25
675.87
599.27
537.04
464.60
Accumulated Depreciation
169.67
115.29
74.15
36.92
308.66
268.96
228.11
190.87
159.73
131.25
Non Current Assets
1,093.64
853.59
772.27
673.34
589.07
563.97
594.06
547.20
456.50
396.26
Capital Work in Progress
92.39
238.15
249.98
237.13
122.64
90.54
132.20
112.76
62.87
62.88
Non Current Investment
129.20
9.20
9.51
5.54
5.83
5.72
5.72
0.03
0.03
0.03
Long Term Loans & Adv.
56.37
31.79
25.57
28.05
44.61
48.42
8.38
26.02
16.29
0.00
Other Non Current Assets
9.39
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
2,039.29
2,331.78
748.46
632.11
564.42
580.68
478.44
439.35
424.79
402.46
Current Investments
800.75
895.55
8.00
8.04
35.04
5.67
33.06
14.50
21.29
59.18
Inventories
338.66
272.86
281.71
230.57
207.68
203.49
143.05
157.96
150.26
107.54
Sundry Debtors
436.05
272.22
315.32
220.09
191.58
196.51
206.95
183.25
185.13
166.97
Cash & Bank
200.99
681.46
16.14
20.13
26.96
52.15
24.64
23.23
15.16
23.64
Other Current Assets
262.83
64.17
28.49
30.51
103.17
122.86
70.75
60.40
52.95
45.13
Short Term Loans & Adv.
194.18
145.51
98.80
122.77
82.25
105.67
61.73
53.14
47.14
45.13
Net Current Assets
1,536.37
1,868.26
355.84
357.02
352.66
350.36
227.32
206.05
248.65
237.12
Total Assets
3,132.93
3,185.37
1,520.73
1,305.45
1,153.49
1,144.65
1,072.50
986.55
881.29
798.72

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
-327.77
-112.34
68.19
111.91
78.10
86.73
171.23
124.08
68.59
129.10
PBT
-57.44
3,241.14
141.25
137.68
77.41
171.17
146.07
94.03
126.66
153.24
Adjustment
6.80
-3,207.66
53.31
39.65
35.57
18.74
47.15
39.37
27.54
25.31
Changes in Working Capital
-264.94
-146.67
-98.65
-34.16
-16.49
-66.32
13.05
13.51
-54.81
-21.95
Cash after chg. in Working capital
-315.57
-113.19
95.91
143.16
96.49
123.58
206.27
146.91
99.39
156.60
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-12.20
0.86
-27.72
-31.25
-18.39
-36.85
-35.04
-22.83
-30.81
-27.50
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-286.01
1,648.67
-127.87
-85.33
-52.34
35.70
-118.45
-101.80
-47.60
-100.15
Net Fixed Assets
-139.02
-107.71
-135.60
154.89
-73.58
38.14
-92.98
-106.47
-67.03
-39.23
Net Investments
-63.59
-889.36
17.40
42.09
-32.73
20.34
-34.14
-5.98
28.17
-67.50
Others
-83.40
2,645.74
-9.67
-282.31
53.97
-22.78
8.67
10.65
-8.74
6.58
Cash from Financing Activity
-2.42
-881.13
59.23
-33.42
-50.95
-94.92
-51.38
-14.21
-29.46
-39.68
Net Cash Inflow / Outflow
-616.19
655.20
-0.46
-6.84
-25.19
27.51
1.41
8.07
-8.48
-10.73
Opening Cash & Equivalents
666.07
11.21
11.67
26.96
52.15
24.64
23.23
15.16
23.64
34.37
Closing Cash & Equivalent
197.05
666.40
11.21
20.13
26.96
52.15
24.64
23.23
15.16
23.64

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
371.69
380.95
116.88
104.93
95.48
90.02
80.27
73.06
68.36
62.36
ROA
-0.75%
108.16%
7.68%
8.82%
6.55%
11.56%
11.00%
7.63%
11.31%
16.36%
ROE
-0.90%
136.04%
10.77%
11.92%
8.95%
16.62%
16.34%
11.16%
16.11%
23.51%
ROCE
-1.77%
162.77%
13.42%
14.97%
9.29%
21.84%
20.13%
14.03%
20.37%
27.72%
Fixed Asset Turnover
1.43
2.21
3.08
2.32
1.71
1.67
1.71
1.55
1.66
1.71
Receivable days
109.51
77.49
63.41
55.72
58.55
64.53
65.42
76.34
77.46
77.49
Inventory Days
93.93
73.14
60.67
59.32
62.03
55.42
50.47
63.88
56.72
51.31
Payable days
74.09
94.61
104.25
52.00
52.61
62.52
65.77
65.64
63.82
75.73
Cash Conversion Cycle
129.34
56.03
19.82
63.05
67.97
57.43
50.11
74.58
70.36
53.06
Total Debt/Equity
0.08
0.06
0.09
0.04
0.03
0.03
0.04
0.11
0.08
0.06
Interest Cover
-6.64
405.79
43.00
48.57
26.45
54.66
45.40
24.06
53.94
65.29

News Update


  • Unichem gets USFDA’s nod for Tramadol Hydrochloride Tablets
    13th Aug 2019, 09:59 AM

    The Product will be commercialized from the company’s Ghaziabad plant

    Read More
  • Unichem gets USFDA’s nod for Chlorthalidone Tablets
    12th Aug 2019, 13:02 PM

    The Product will be commercialized from Unichem's Ghaziabad plant

    Read More
  • USFDA completes inspection at Unichem Laboratories’ Goa formulation facility
    1st Aug 2019, 09:52 AM

    At the end of Inspection, the facility received 4 observations, with no repeat observations and are mostly procedural in nature

    Read More
  • Unichem Lab - Quarterly Results
    27th Jul 2019, 13:36 PM

    Read More
  • Unichem Laboratories incorporates WOS in China
    8th Jul 2019, 11:59 AM

    The business license and various clarifications on the same were received by the Company on July 4, 2019

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.